BCR-ABL: A Personal Journey into Precision Oncology—Our Chief Scientist’s role in the discovery that led to Gleevec and launched targeted therapy
As Chief Scientist at Cancer Commons, Emma Shtivelman, PhD, applies her deep expertise and compassion to help cancer patients, their loved ones, and their care teams navigate personalized treatment options based on the best, most up-to-date evidence. But her influence extends far beyond the lives she’s touched directly. Here, our Curious Dr. George asks her about an early-career discovery that would help save many lives and usher in the era of precision oncology.
August 10, 2026
.png)